Amanda Delaney, DPM
Foot & Ankle Surgery · Nashua, NHNPI 1992185169
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Stryker at 47.4% of the total. Reporting peaked in 2019 at $1,475 and has fallen 63.4% since, to $541 in 2025.
Across 57 payments — averaging $55.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medical Device Business Services, Inc.$937
- Johnson & Johnson$197
- Organogenesis Inc.$140
- Bioventus LLC$83
- Smith+Nephew$80
- plus $232 from 7 others
What the payments were for
- Travel & lodging$1,74155%
- Food & beverage$1,42845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 24 | $1,501 |
| Medical Device Business Services, Inc. | 6 | $937 |
| Johnson & Johnson | 3 | $197 |
| Organogenesis Inc. | 4 | $140 |
| Bioventus LLC | 3 | $83 |
| Smith+Nephew | 6 | $80 |
| AbbVie | 5 | $76 |
| Lifenet Health | 1 | $65 |
| Aroa Biosurgery Incorporated | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $19 |
| Amgen | 1 | $16 |
| Integra Lifesciences Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,170 in reported general payments places this provider in the 75th percentile of 23 foot & ankle surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 11 | $337 |
| Clotrimazole | 15 | $280 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $144 |
| Methylprednisolone | 24 | $126 |
| Clindamycin Hcl | 12 | $88 |
| Cephalexin | 18 | $79 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $74 |
| Meloxicam | 16 | $48 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Nashua
- Michael KellyNashua$7K
- David CourtNashua$183
- Marc MichaudManchester$17K
- Jonathan LeeManchester$8K
- John GregoryLebanon$7K
- N Jake SummersManchester$4K
- Breton FoxManchester$3K
- Kristin ViscoManchester$2K
- David HoeftNorth Conway$1K
- Peter KasyjanskiManchester$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.